Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Abeer A. Elkhoely"'
Autor:
Abeer A. Elkhoely, Abeer A. El Sayed, Yasmin M. Attia, Mohamed S. Elsesy, Nebal El Tanbouly, Samia A. Shouman, Mouchira A. Choucry, Essam Abdel Sattar, Sabah H. El Gayed, Amira S. El Senousy, Shahira M. Ezzat
Publikováno v:
Scientific Reports, Vol 8, Iss 1, Pp 1-16 (2018)
Scientific Reports
Scientific Reports
The objective of our study is to highlight the therapeutic effect and mechanism of action by which purified Flaxseed hydrolysate (PFH) which is a lignan rich fraction exerts its anticancer activity on a human breast cancer cell line (T47D) and in mic
Autor:
Abeer A. Elkhoely, Ahmed M. Kabel
Publikováno v:
Biomedicine & Pharmacotherapy. 93:17-26
The aim of this study was to assess the possible modulatory effects of rosuvastatin and/or ubiquinone on trastuzumab (TRZ)-induced cardiotoxicity in mice. One hundred and twenty mice were divided into six equal groups as follows: control group; TRZ g
Publikováno v:
Toxicology mechanisms and methods. 30(3)
Diallyl sulfide (DAS) is a garlic-derived organosulfur compound. The current study was planned to evaluate the protecting effects of DAS against cyclophosphamide (CP)-induced nephropathic encephalopathy. DAS (100 mg/kg) was orally administered for 4
Autor:
Abeer A. Elkhoely
Publikováno v:
Journal of Biochemical and Molecular Toxicology. 33
The underlined effects of diallyl sulfide (DAS) against CCL4 -induced oxidative, inflammatory, and apoptotic acute hepatic damage were assessed. Administration of DAS (50, 100, and 200 mg/kg) along with CCL 4 effectively mitigated serum aspartate ami
Autor:
Abeer A. Elkhoely, Mohamed Nabih Abdel-Rahman, Ahmed M. Kabel, Almokhtar A. Adwas, Amany A. Eissa
Publikováno v:
International Journal of Pharmacology, Phytochemistry and Ethnomedicine. 4:61-72
Background: Ehrlich carcinoma is a transplantable tumor model used frequently in cancer studies. Doxorubicin (DOX) is one of the anthracyclines that is frequently used in treatment of various types of malignancies including breast, prostate and lung
Autor:
Abeer A. Elkhoely, Ahmed M. Kabel, Amany A. Eissa, Mohamed Nabih Abdel-Rahman, Almokhtar A. Adwas
Publikováno v:
Journal of Infection and Chemotherapy. 22:36-43
Doxorubicin (DOX) is a broad-spectrum antitumor antibiotic used in treatment of cancer. Its effect may be complicated by increased risk of cardiotoxicity. It was suggested that natural compounds with anticancer properties can be used in combination w
Publikováno v:
Naunyn-Schmiedeberg's archives of pharmacology. 391(5)
Pancreatic cancer, the fourth most common cause of cancer-related deaths, is one of the most aggressive and devastating human malignancies with increasing incidence worldwide. To date, surgical resection is the only potentially curative therapy avail
Autor:
Abeer A. Elkhoely, Ahmed M. Kabel
Publikováno v:
Tissuecell. 48(2)
Breast cancer is one of the most common types of malignancies in females worldwide. Targeting the estrogen receptors alone with raloxifene (RAL) reduces the incidence of estrogen receptor positive tumors. Fluoxetine (FLX) is one of selective serotoni
Autor:
Abeer A. Elkhoely, Osama A. Badary, Samia A. Shouman, Hafez F. Hafez, Abeer M. Ashmawy, Adel M. Mostafa, Ahmed Abdelaziz
Publikováno v:
Journal of natural medicines. 69(3)
Liver cancer is the fifth commonest malignancy worldwide and the third leading cause of death. Identifying novel curative and preventive therapy may improve its prognosis. In this study, thymoquinone (TQ), the most active biological ingredient of Nig
Autor:
Mahmoud SA; Pharmacology and Toxicology Department, Faculty of Pharmacy, Helwan University, Ein Helwan, Cairo, Egypt., Elkhoely A; Pharmacology and Toxicology Department, Faculty of Pharmacy, Helwan University, Ein Helwan, Cairo, Egypt. abir_alkholy@pharm.helwan.edu.eg., El-Sayed EK; Pharmacology and Toxicology Department, Faculty of Pharmacy, Helwan University, Ein Helwan, Cairo, Egypt., Ahmed AAE; Pharmacology and Toxicology Department, Faculty of Pharmacy, Helwan University, Ein Helwan, Cairo, Egypt.
Publikováno v:
Naunyn-Schmiedeberg's archives of pharmacology [Naunyn Schmiedebergs Arch Pharmacol] 2024 Aug; Vol. 397 (8), pp. 6177-6195. Date of Electronic Publication: 2024 Mar 05.